FFC#20/2016

Italian multicenter study of glucose tolerance defects in cystic fibrosis

AREA 5 Clinical and Epidemiological research

FFC#20/2016

Italian multicenter study of glucose tolerance defects in cystic fibrosis
€ 0 still needed
0%
€ 80.000 goal

pRINCIPAL INVESTIGATOR

Alberto Battezzati (Centro Internazionale per lo Studio della Composizione Corporea – ICANS, DeFENS, Università degli Studi di Milano)

Partner

Carla Colombo (Dip. di Scienze Materno Infantili, Università di Milano e Centro Regionale FC, Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Clinica Pediatrica De Marchi, Milano); Vincenzina Lucidi (Ospedale Pediatrico Bambin Gesù, Roma); Giuseppe Magazzù (Dip. di Patologia Umana dell’adulto e dell’età evolutiva Gaetano Barresi, Università di Messina); Andrea Mari (Istituto di Neuroscienze, Consiglio Nazionale delle Ricerche IN-CNR, Padova)

Researchers

18

Category

AREA 5 Clinical and Epidemiological research

Duration

2 years

Goal

€ 80.000

Funds raised

€ 80.000

Objectives

The objective is to create for the Italian CF population reference values of the glucose, insulin and c-peptide concentrations in response to OGTT, and of model-derived parameters of insulin secretion and insulin sensitivity. This investigation should provide a better definition of the relationship of insulin secretory defects with age, sex, pancreatic insufficiency, liver disease and new CF therapies. Previous single-center experience (Milan) will be shared with centers from Central and Southern Italy in order to collect the largest number of patients. National parameters will allow to predict future CFRD, nutritional and respiratory decay and to set a rational basis for treatment.

WHO ADOPTED THE PROJECT

Delegazione FFC di Latina

€ 20.000

Delegazione FFC di Villa D’Almè

€ 8.000

Ma.Gia srl

€ 10.000

Associazione Trentina Fibrosi Cistica in ricordo di Marika Tomasi

€ 20.000

Delegazione FFC di Milano

€ 22.000

Delegazione FFC di Novara

€ 8.000

OTHER PROJECTS

Discover the other projects

GMSG#1/2025

Developing PNAs to Block Essential Bacterial Genes and Create New Antimicrobial Therapies

FFC#1/2025

Understanding the process of epithelial-mesenchymal transition to preserve tissue function and reduce long-term complications (e.g. cancer)

FFC#2/2025

Developing RNA-targeted therapies to regulate gene expression and restore CFTR synthesis